Controlled-release transdermal patches represent a sophisticated method for delivering therapeutic compounds through the skin, directly into the bloodstream. At CD Formulation, we specialize in formulation design, optimization, and regulatory compliance, ensuring precision in drug release kinetics. We provide custom development of controlled release transdermal patches tailored to researchers' requirements.
Controlled-release transdermal patches utilize advanced program-controlled transdermal therapeutic systems. The five-layer structure consists of a backing layer, drug reservoir layer, controlled-release layer, contact adhesive layer, and anti-adhesive protective layer. Once applied, a concentration gradient forms between the drug-saturated polymer reservoir and the skin, promoting a consistent drug release rate. Our innovative microporous filter membrane technology precisely controls the release rate, enabling effective drug delivery through subcutaneous capillaries.
Controlled release transdermal patches offer numerous advantages over traditional delivery methods, including:
Fig.1 The advantages of controlled release transdermal patches. (CD Formulation)
At CD Formulation, we offer a range of custom-controlled release transdermal systems, including:
In this type of system, the drug reservoir is encapsulated in a shallow compartment molded from a drug-impermeable metallic laminate and a rate-controlling membrane which may be micro-porous or non-porous. The drug molecules are permitted to be released only through the rate-controlling membrane. In the drug reservoir compartment, the drug solids are either dispersed in a solid polymer matrix or suspended in an unreachable, viscous liquid medium such as silicone fluid to form a paste-like suspension.
In this approach, the drug reservoir is prepared by homogenously dispersing drug particles in a hydrophilic or lipophilic polymer matrix. Use the swelling and dissolution characteristics of the polymer skeleton to control the release process of the drug.
The microneedle system is based on the integral molding of micron-sized needles on the patch substrate, which expands the range of drug molecules and formulations that can be delivered to the skin by painlessly mechanically destroying the skin barrier. The design of a microneedle system with a controlled drug release pattern is mainly affected by the inherent properties of the matrix material, drug binding affinity, and the in vivo environment.
Fig.2 Strategies to develop polymeric microneedles for controlled drug release. (Bo Zhi Chen, et al. 2023)
We employ state-of-the-art technologies to enhance transdermal absorption:
Technology: Technology for microneedle-based systems for controlled drug release
Journal: Advanced Drug Delivery Reviews
IF: 15.2
Published: 2023
Results: The microneedle system is built on the integral formation of micron-scale needles onto a patch substrate, which can expand the range of drug molecules and formulations open to dermal delivery through the pain-free mechanical disruption of the skin barriers. For such a barrier-disruption mechanism, effective transport of diverse bioactive materials into the skin by a brief microneedle administration is desirable while avoiding skin injury, neatly integrating the benefits of skin injection and the safety of transdermal patch.
CD Formulation remains committed to advancing the field of transdermal drug delivery, providing customized solutions for research and development. For inquiries, please contact us, and our team will respond within three business days.
References